XT
FENC icon

XTX Topco’s Fennec Pharmaceuticals FENC Stock Holding History

XTX Topco’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
93,866
+78,611
+515% +$642K 0.01% 1782
2026
Q1 		$93.8K Sell
15,255
-11,531
-43% -$89K ﹤0.01% 3122
2025
Q4 		$206K Buy
26,786
+5,539
+26% +$45.5K 0.01% 2377
2025
Q3 		$199K Buy
+21,247
New +$184K 0.01% 1852

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco's FENC Position: Q2 2026 in Review

XTX Topco increased its Fennec Pharmaceuticals (FENC) stake by 515% in Q2 2026, buying an estimated $642K and bringing the position to 93,866 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #1782.

XTX Topco first reported a position in FENC in Q3 2025 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • XTX Topco held 93,866 shares of Fennec Pharmaceuticals worth $1.01M as of Q2 2026.
  • XTX Topco bought 78,611 Fennec Pharmaceuticals shares in Q2 2026, an estimated $642K.
  • Fennec Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1782 holding.
  • XTX Topco first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.